The Effect Of Probiotics On Bowel Function Restoration After Ileostomy Closure In Patients With Rectal Cancer
NCT ID: NCT02751736
Last Updated: 2017-04-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2016-04-30
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Symbiotics to Prevent Postoperative Infection in Colorectal Cancer
NCT02571374
Anal Dilatation Plus Probiotics Before Ileostomy Reduction for Low Anterior Resection Syndrome
NCT04688242
Early Ileostomy Closure for Rectal Cancer Patients in North America
NCT05027737
Synbiotics and Gastrointestinal Function Related Quality of Life After Colectomy for Cancer
NCT01479907
Early Closure of Protective Ileostomy in Rectal Cancer Patients
NCT02997267
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
* 2 g sachet (CJLP 243) once a day for 3 weeks
* 10 billion lactic acid bacteria(lactobacillus plantarum CJLP243), maltodextrin, glucose(anhydrous)
CJLP243
Perioperative administration till postoperative weeks 3
Control
* 2g sachet (near identically appearing placebo) once day for 3 weeks
* maltodextrin, glucose(anhydrous)
Placebo
Perioperative administration till postoperative weeks 3
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CJLP243
Perioperative administration till postoperative weeks 3
Placebo
Perioperative administration till postoperative weeks 3
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with rectal cancer
* s/p low anterior resection (double stapled anastomosis)
Exclusion Criteria
* Pregnancy
* Valvular heart disease
* s/p intersphincteric resection (index surgery)
* h/o anastomotic leakage (index surgery)
* medically unfit (cardiopulmonary dysfunction, sepsis etc)
20 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HK inno.N Corporation
INDUSTRY
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Heung-Kwon Oh
Clinical Associate Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B-1603-339-003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.